Glenmark Pharmaceuticals Ltd Q3 FY2023-2024 Results: Summary
Revenue | ₹2,670.88Cr |
Net Profits | ₹-351.37Cr |
Net Profit Margins | -13.16% |
Highlights
Revenue:
Glenmark Pharmaceuticals Ltd’s revenue fell -19.3% since last year same period to ₹2,670.88Cr in the Q3 2023-2024. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -19.74% fall in its revenue since last 3-months.
Net Profits:
Glenmark Pharmaceuticals Ltd’s net profit fell -228.91% since last year same period to ₹-351.37Cr in the Q3 2023-2024. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -328.76% fall in its net profits since last 3-months.
Net Profit Margins:
Glenmark Pharmaceuticals Ltd’s net profit margin fell -259.73% since last year same period to -13.16% in the Q3 2023-2024. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -434.22% fall in its net profit margins since last 3-months.
